INSUBCONTINENT EXCLUSIVE:
violating insider trading norms
On the National Stock Exchange (NSE), the Aurobindo Pharma stock price dropped as much as 4.55 per cent to Rs 588.90.Sebi's penalty is for
Kambam P Reddy, Trident Chemphar, a company belonging to the promoter group of Aurobindo Pharma, Veritaz Healthcare and Top Class Capital
Markets between July 2008 and March 2009 when the company entered into a licensing agreement with US-based Pfizer.According to Sebi's
investigation, Pfizer and Aurobindo Pharma entered into certain licensing and supply agreements on July 22, 2008, November 30, 2008 and
The press releases for this information were issued by both companies on March 3, 2009."The said press releases were followed by an increase
in price of the scrip of Aurobindo Pharma
During which the licensing and supply agreements had been entered into but not published or disclosed to the stock exchange between July 22,
2008 and March 3, 2009 is hereinafter referred to as the unpublished price-sensitive information period," Sebi said.The promoters and the
above mentioned individuals were found to have traded in the scrip of Aurobindo Pharma prior to the information about the licensing and
supply agreements becoming public through the Press Release dated March 3, 2009, hence violating the Prohibition of Insider Trading norms,
the market regulator said.At 11:17 am, Aurobindo Pharma shares traded 0.79 per cent lower at Rs 608.95 apiece on the BSE, underperforming
the Sensex which was down 0.24 per cent.Get Breaking news, live coverage, and Latest News from India and around the world on
TheIndianSubcontinent.com
Catch all the Live TV action on TheIndianSubcontinent 24x7 and TheIndianSubcontinent India
Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.
